SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
Globe Newswire•09/11/2026•16:01 ET
5
Key Highlights
- ➤Nine-month revenue $48.6M, down from $90.8M year over year
- ➤Nine-month net income $6.1M, down from $28.7M year over year
- ➤Canada awarded SIGA up to $15M oral TPOXX procurement contract
- ➤U.S. 19C contract final order delivered, totaling approximately $26M in nine months
- ➤SIGA continues pursuing a new U.S. Government TPOXX procurement contract
Expert Statements
Diem Nguyen, Chief Executive Officer of SIGA Technologies
“While we continue to work with the U.S. Government toward a new TPOXX procurement contract, our international business remains an important part of our strategy”
Diem Nguyen, Chief Executive Officer of SIGA Technologies
“We recently announced a $15 million contract with the Canadian Department of National Defence, a longstanding customer, and are actively pursuing opportunities with other international governments to further diversify our customer base over time.”
* Awarded $15 Million Procurement Contract from Canadian Department of National Defence for Oral TPOXX in October
* Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2026.
Get started
Create a free account to read the full story.